Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NTSR2 | O95665 | 4/20 | 0.39 |
| ▸ | NTSR1 | P30989 | 4/20 | 0.39 |
| ▸ | APLNR | P35414 | 1/20 | 0.39 |
| ▸ | NMUR2 | Q9GZQ4 | 2/20 | 0.38 |
| ▸ | NMUR1 | Q9HB89 | 2/20 | 0.38 |
| ▸ | GNRHR | P30968 | 3/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.38 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.38 |
| ▸ | NPY1R | P25929 | 1/20 | 0.37 |
| ▸ | NPY2R | P49146 | 1/20 | 0.37 |
| ▸ | NPY4R | P50391 | 1/20 | 0.37 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.37 |
| ▸ | CAPN1 | P07384 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29383471 | 0.87 | GNRHR (0.45) | NTSR2NTSR1APLNRGNRHRCAPN1 | |
| SCHEMBL29615168 | 0.87 | GNRHR (0.45) | NTSR2NTSR1APLNRGNRHRCAPN1 | |
| SCHEMBL8773027 | 0.83 | APLNR (0.43) | NTSR2NTSR1APLNRNMUR2NMUR1 | |
| SCHEMBL29391291 | 0.81 | GNRHR (0.47) | NTSR2NTSR1GNRHR | |
| SCHEMBL30440639 | 0.79 | OPRM1 (0.47) | APLNRNMUR2NMUR1NPY1RNPY2R | |
| SCHEMBL30440642 | 0.79 | OPRM1 (0.47) | APLNRNMUR2NMUR1NPY1RNPY2R | |
| Acetic Acid SCHEMBL30440885 | 0.77 | OPRM1 (0.48) | APLNRNMUR2NMUR1 | |
| SCHEMBL14172897 | 0.76 | APLNR (0.43) | APLNRNMUR2NMUR1GNRHRCAPN1 | |
| SCHEMBL32670190 | 0.76 | OPRK1 (0.61) | NMUR2NMUR1GNRHR | |
| SCHEMBL30423100 | 0.75 | APLNR (0.45) | NTSR2NTSR1APLNRNMUR2NMUR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109929007-B | Preparation method of degarelix key dipeptide intermediate | 连云港恒运药业有限公司 | 2023-07-28 | — | — | CN | disclosed |
| CN-109929012-B | Preparation method of degarelix key tetrapeptide intermediate | 连云港恒运药业有限公司 | 2023-07-28 | — | — | CN | disclosed |
| CN-107955061-B | Preparation method of degarelix key intermediate | 连云港恒运药业有限公司 | 2021-07-30 | — | — | CN | disclosed |